Actavis Fentanyl Patch Recall Lawsuit

Tweet

Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System

October 21, 2010 - Actavis Inc. today announced a recall to the wholesale and retail levels of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches manufactured for Actavis by Corium International in the United States.

Actavis identified one lot of 25 mcg/hour Fentanyl patch (Control/Lot # 30349) shipped to market that contained one patch that released its active ingredient faster than the approved specification in laboratory testing. An accelerated release of Fentanyl from a 25 mcg/hour patch can lead to adverse events for at-risk patients including (but not limited to):

• excessive sedation
• respiratory depression
• hypoventilation (slow breathing)
• apnea (temporary suspension of breathing)

The patches are packaged individually and boxed in quantities of five patches per box. The Control/Lot number appears on the bottom of the product box and on the black and white side of each individual patch packaging, in the lower left corner.

Do I have an Actavis Fentanyl Patch Lawsuit?

The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in fentanyl patch overdose injury accident lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.

Free Fentanyl Patch Recall Case Evaluation: If you or a loved one has experienced an overdose of fentanyl due to a Duragesic patch malfunction, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.